Day: April 16, 2020
CALHOUN, Ga., April 16, 2020 (GLOBE NEWSWIRE) — Mohawk Industries, Inc. (NYSE: MHK) kondigde vandaag de benoeming aan van Frank H. Boykin tot Chief Financial Officer, met ingang van 15 april 2020.“Tijdens de 25 jaar die Frank voor het bedrijf werkzaam is, heeft hij een belangrijke rol gespeeld bij de groei van Mohawk”, aldus Jeff Lorberbaum, voorzitter en Chief Executive Officer van Mohawk. “Hij heeft ervoor gezorgd dat ons financiële team beter presteert en het vertrouwen gewonnen van investeerders en analisten. Ik heb Frank gevraagd om de verantwoordelijkheden van Chief Financial Officer weer op zich te nemen, omdat zijn kennis van alle aspecten van onze bedrijfsvoering en de branche een grote aanwinst is voor ons in deze omgeving.”Boykin, 64, was van 2005 tot 2019 werkzaam als Chief Financial Officer van...
莫霍克 (Mohawk) 任命 Frank Boykin 擔任財務總監
Written by Customer Service on . Posted in Public Companies.
喬治亞州卡爾霍恩, April 17, 2020 (GLOBE NEWSWIRE) — 莫霍克工業公司 (Mohawk Industries, Inc.,紐約證券交易所代碼:MHK) 今天宣佈任命 Frank H. Boykin 為財務總監,並由 2020 年 4 月 15 日起生效。Mohawk 主席兼行政總裁 Jeff Lorberbaum 說:「Frank 在任職的 25 年間,對 Mohawk 的成長發揮非常重要的角色。他提升了我們財務團隊的業績表現,並贏得了投資者及分析員的信心。我已要求 Frank 恢復財務總監的職責,因為在這種環境下,他對我們業務和業界各方面的了解是我們寶貴的財富。」64 歲的 Boykin 曾於 2005 年至 2019 年擔任 Mohawk 的財務總監。他最初於 1993 年加入公司,擔任公司財務總監。Boykin 於 2019 年退休,並在過去一年間繼續以高級顧問的身份支持公司業務。Boykin 說:「我很高興回到 Mohawk,並幫助公司業務過渡這個充滿挑戰的時代。在擔任顧問職務時,我與公司一直保持密切聯繫,並準備隨時介入。我期待著重新加入公司出色的財務團隊,並與領導層一起管理計劃,以幫助公司從目前低迷的市場中復蘇。」前財務總監 Glenn Landau 將於 2020 年 4 月 15 日離開公司,以追求其他個人興趣。關於莫霍克工業 (MOHAWK INDUSTRIES)Mohawk Industries 是全球領先的地板製造商,致力於創造產品來提升全球住宅和商業空間。Mohawk 垂直整合的製造和分銷流程在地毯、小毛毯、瓷磚、層壓板、木材、石材和乙烯基地板的生產方面擁有競爭優勢。我們在業界領先的創新產品和技術使我們的品牌在市場上脫穎而出,並滿足所有改造和新建工程要求。我們是在行內最受認可的品牌,並包括 American Olean、Daltile、Durkan、Feltex、Godfrey Hirst、IVC、Karastan、Marazzi、Mohawk、Mohawk...
Mohawk任命Frank Boykin为首席财务官
Written by Customer Service on . Posted in Public Companies.
美国佐治亚州卡尔霍恩, April 17, 2020 (GLOBE NEWSWIRE) — Mohawk Industries, Inc.(NYSE: MHK)今天宣布任命Frank H. Boykin为首席财务官,2020年4月15日起生效。“自25年前加入公司以来,Frank在Mohawk的发展中发挥了重要作用,”Mohawk董事长兼首席执行官Jeff Lorberbaum表示。“他提升了我们财务团队的绩效,获得了投资者和分析师的信任。我已请Frank重新承担首席财务官的职责,因为他对我们业务和行业各个方面的了解是我们在当前环境中的一项重要资产。”Boykin现年64岁,曾于2005年至2019年间担任Mohawk的首席财务官。他最初于1993年作为公司主计长加入公司。Boykin于2019年退休,去年他作为高级顾问继续为企业提供支持。“我很高兴回到Mohawk,帮助企业应对这一充满挑战的时刻,”Boykin表示。“作为顾问,我一直与企业保持着紧密联系,可以随时投入工作。我期待着重新加入我们杰出的财务团队,并与领导团队合作管理各项举措,为我们从当前的经济衰退中崛起助一臂之力。”前首席财务官Glenn Landau将于2020年4月15日离开公司,以追求其他事业。关于MOHAWK INDUSTRIESMohawk Industries是全球领先的地材制造商,致力于创造可提升全球住宅和商业空间的优质产品。Mohawk的垂直整合生产和分销流程在生产地毯、地垫、瓷砖、复合地板、木地板、石材和乙烯基地材方面具有竞争优势。公司业界领先的创新产品和技术使其品牌在市场上脱颖而出,满足所有的装修和新建需求。我们公司旗下品牌在业内受到最广泛的认可,包括:American Olean、Daltile、Durkan、Eliane、Feltex、Godfrey Hirst、IVC、Karastan、Marazzi、Mohawk、Mohawk Group、Pergo、Quick-Step和Unilin。过去十年里,Mohawk已从一家美国地毯生产商成功转型为全球最大的地材公司,业务遍及澳大利亚、巴西、加拿大、欧洲、印度、马来西亚、墨西哥、新西兰、俄罗斯和美国等地。前面几段陈述中的某些内容,特别是预测未来业绩、业务前景、增长、经营策略以及类似事项和包括“可能”、“应该”、“相信”、“预期”、“预测”、“估计”或类似表达的词句均构成“前瞻性陈述”。针对以上陈述,Mohawk有权要求受到1995年《私人证券诉讼改革法案》中关于前瞻性陈述的安全港保护。前瞻性陈述建立于诸多涉及风险和不确定性的假设基础上,因此我们无法保证其准确性。以下重要因素的改变可能导致未来业绩发生变化:经济或行业状况、竞争、原材料价格、其他投入成本的通货膨胀和通货紧缩、消费市场的通货膨胀和通货紧缩、能源成本和供应、资本支出的时间和水平、公司产品价格上涨的时间和实施、减值费用、收购整合、国际业务、推出新产品、运营合理化、税收和税收改革、产品和其他索赔、诉讼、与COVID-19疫情相关的风险及不确定性以及Mohawk提交给美国证券交易委员会的报告和公告中提及的其他风险。联系人:Frank...
Mohawk nomme Frank Boykin au poste de directeur financier
Written by Customer Service on . Posted in Public Companies.
CALHOUN, Géorgie, 16 avr. 2020 (GLOBE NEWSWIRE) — Mohawk Industries, Inc. (NYSE : MHK) a annoncé aujourd’hui la nomination de Frank H. Boykin au poste de directeur financier, à compter du 15 avril 2020.« Au cours de ses 25 ans de carrière dans l’entreprise, Frank a joué un rôle important dans la croissance de Mohawk », a déclaré Jeff Lorberbaum, président-directeur général de Mohawk. « Il a amélioré les performances de notre équipe financière et gagné la confiance des investisseurs et des analystes. J’ai demandé à Frank de reprendre ses responsabilités de directeur financier parce que sa connaissance de tous les aspects de notre entreprise et de l’industrie est un atout majeur pour nous dans le contexte actuel. »M. Boykin, 64 ans, a occupé le poste de directeur financier de Mohawk de 2005 à 2019. Il a initialement...
Repeat: Pixium Vision Reports Cash Position as of March 31, 2020, and provides business and financial update with cash runway extended until Q1 2021
Written by Customer Service on . Posted in Public Companies.
Paris, France. April 16, 2020 – 18:00 PM CEST – Pixium Vision (FR0011950641 – ALPIX), a bioelectronics company developing innovative bionic vision systems to enable patients who have lost their sight to lead more independent lives, announces its cash position of €4.8 million as of March 31st, 2020 and provides an update on its latest business developments.Use of cash flow from operating activities amounted to €2.5 million and €3.0 million at March 31, 2020 and March 31, 2019, respectively. The decrease in cash burn is mostly due to the delayed payment of social charges following the French government measures to help French companies through the Covid-19 situation. The cash consumption from R&D activities in Q1 2020 was also lower compared to Q1 2019 due to lower spending on the Prima 2 transparent glasses, as the study...
Repeat: Pixium Vision annonce sa position de trésorerie au 31 mars 2020 et fait le point sur ses activités et sa visibilité financière jusqu’au premier trimestre 2021
Written by Customer Service on . Posted in Public Companies.
Paris, le 16 avril 2020 – 18:00 CEST – Pixium Vision (Euronext Growth Paris – FR0011950641 – ALPIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue de vivre de façon plus autonome, annonce une position de trésorerie de 4,8 millions d’euros au 31 mars 2020 et communique sur ses principaux développements.La consommation nette de trésorerie liée aux activités opérationnelles au cours des trois premiers mois de 2020 s’est élevée à 2,5 millions d’euros contre 3,0 millions d’euros un an auparavant. Le recul de la consommation de trésorerie est principalement lié au report du paiement des charges sociales dans le cadre des mesures économiques prises par le gouvernement français pour soutenir les entreprises face à la pandémie de Covid-19. La réduction...
QuestCap to Acquire 49 Percent of Athletics and Health Solutions Inc. With Intent to Deploy COVID-19 Standard for Safe Sport With Colombian Professional Soccer League
Written by Customer Service on . Posted in Public Companies.
TORONTO, April 16, 2020 (GLOBE NEWSWIRE) — QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) announced today that the Company has executed a share purchase agreement (the “A&H Agreement”) to acquire 49 percent of the issued and outstanding shares of Athletics and Health Solutions Inc. (“A&H”), a recently incorporated private Ontario corporation which has entered into a non-binding letter of intent (the “LOI”) on April 14, 2020 with the Division Mayor del Futbol Colombiano (“DIMAYOR”), the organization responsible for operating professional football leagues and tournaments in Colombia, to restart football activities in Colombia.Under the terms of the A&H Agreement, QuestCap is to issue a total of 6 million common shares to four arm’s length vendors of the A&H common shares. Based on the April 15,...
NVIDIA Receives Approval to Proceed with Mellanox Acquisition from China’s Antitrust Authority
Written by Customer Service on . Posted in Public Companies.
SANTA CLARA, Calif., April 16, 2020 (GLOBE NEWSWIRE) — NVIDIA today announced that it has received approval from all necessary authorities to proceed with its planned acquisition of Mellanox, as announced in March 2019.The latest approval by China’s State Administration for Market Regulation follows antitrust approval from the European Commission and Mexico and the expiration of the waiting period under U.S. antitrust laws. With the exception of the remaining customary closing conditions, all conditions to the deal’s closing have been satisfied.NVIDIA announced on March 11, 2019, its intention to acquire Israel-based Mellanox for $125 per share in cash, or $6.9 billion, in a transaction that would combine NVIDIA’s leading computing expertise with Mellanox’s high-performance interconnect technology. The acquisition is expected to...
Ritter Pharmaceuticals, Inc. Announces Form S-4 Registration Statement Declared Effective by SEC
Written by Customer Service on . Posted in Public Companies.
Special Meeting of Ritter Pharmaceuticals, Inc. Stockholders to Vote on Proposed Merger Scheduled for May 14, 2020LOS ANGELES , April 16, 2020 (GLOBE NEWSWIRE) — Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, Ritter” or the “Company”), a developer of therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, today announced that the U.S. Securities and Exchange Commission (the “SEC”) has declared effective its Registration Statement on Form S-4 relating to its previously announced proposed merger with Qualigen, Inc. (“Qualigen”) pursuant to the Agreement and Plan of Merger, dated as of January 15, 2020, as amended, by and among Ritter, RPG28 Merger Sub, Inc., and Qualigen.The special meeting of Ritter stockholders to vote on certain matters related to the proposed merger will...
AzurRx Announces Manufacturing Agreement with Delpharm for MS1819 Clinical Drug Product
Written by Customer Service on . Posted in Public Companies.
NEW YORK, April 16, 2020 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has entered into a manufacturing agreement with Delpharm (“Delpharm”), a leading contract development manufacturing organization (CDMO), for the clinical drug product supply of its MS1819 therapy for exocrine pancreatic insufficiency (EPI). Under the terms of the agreement, Delpharm will manufacture AzurRx’s MS1819 cGMP batch that will be used in the Phase 2b OPTION 2 Clinical Trial for the treatment of EPI in patients with Cystic Fibrosis (CF). As preparation for the cGMP batch, the drug product manufacturing process was transferred to Delpharm and they have successfully produced a non-GMP...